Literature DB >> 19589256

The role of c-Jun N-terminal kinases 1/2 in transforming growth factor beta(1)-induced expression of connective tissue growth factor and scar formation in the cornea.

Y Chang1, X-Y Wu.   

Abstract

Transforming growth factor beta(1) (TGF-beta(1)) plays an important role in corneal scar formation, mediated by connective tissue growth factor (CTGF). This study was designed to investigate the effect of c-Jun N-terminal kinase (JNK) 1 and 2 on TGF-beta(1)-regulated CTGF gene expression and corneal scar formation in telomerase-immortalized human corneal stroma fibroblast (THSF) cells. The effects of CTGF, TGF-beta(1) and a JNK inhibitor (SP600125) on the proliferation of THSF cells were studied using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Both CTGF and TGF-beta(1) increased THSF cell proliferation and SP600125 inhibited this effect. Immunofluorescence analysis showed that TGF-beta(1) stimulated the activation of JNK1/2 and induced cell migration, effects that were inhibited by SP600125. Analysis by real-time reverse transcription-polymerase chain reaction showed that the mRNA levels of the genes for CTGF, fibronectin and collagen Ialpha(1) in wound and corneal scar formation were reduced by SP600125 pre-treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19589256     DOI: 10.1177/147323000903700316

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  10 in total

1.  FGF-2- and TGF-β1-induced downregulation of lumican and keratocan in activated corneal keratocytes by JNK signaling pathway.

Authors:  Jian Chen; Julie Wong-Chong; Nirmala SundarRaj
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-21       Impact factor: 4.799

Review 2.  Role of transforming growth factor Beta in corneal function, biology and pathology.

Authors:  A Tandon; J C K Tovey; A Sharma; R Gupta; R R Mohan
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

3.  Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.

Authors:  Kye-Im Jeon; Richard P Phipps; Patricia J Sime; Krystel R Huxlin
Journal:  Exp Eye Res       Date:  2015-07-02       Impact factor: 3.467

4.  JNK1/2 siRNA inhibits transforming-growth factor-beta1-induced connective tissue growth factor expression and fibrotic function in THSFs.

Authors:  Yuan Chang; Xin-Yi Wu
Journal:  Mol Cell Biochem       Date:  2009-09-18       Impact factor: 3.396

5.  Activation of JNK signaling mediates connective tissue growth factor expression and scar formation in corneal wound healing.

Authors:  Long Shi; Yuan Chang; Yongmei Yang; Ying Zhang; Fu-Shin X Yu; Xinyi Wu
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

6.  A crosstalk between the Smad and JNK signaling in the TGF-β-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells.

Authors:  Qinghua Liu; Yu Zhang; Haiping Mao; Wei Chen; Ning Luo; Qin Zhou; Wenfang Chen; Xueqing Yu
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

7.  Rosiglitazone inhibits TGF-β 1 induced activation of human Tenon fibroblasts via p38 signal pathway.

Authors:  Yong-Heng Luo; Ping-Bo Ouyang; Jiao Tian; Xiao-Jian Guo; Xuan-Chu Duan
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

Review 8.  JNK Signaling as a Key Modulator of Soft Connective Tissue Physiology, Pathology, and Healing.

Authors:  Georgia Nikoloudaki; Sarah Brooks; Alexander P Peidl; Dylan Tinney; Douglas W Hamilton
Journal:  Int J Mol Sci       Date:  2020-02-04       Impact factor: 5.923

9.  Exploring the Key Genes and Pathways in the Formation of Corneal Scar Using Bioinformatics Analysis.

Authors:  Binfeng Liu; Ang Li; Hongbo Wang; Jialin Wang; Gongwei Zhai; Haohao Ma; Shiqing Feng; Liyun Liu; Yanzheng Gao
Journal:  Biomed Res Int       Date:  2020-01-18       Impact factor: 3.411

10.  TGF-β-Mediated Modulation of Cell-Cell Interactions in Postconfluent Maturing Corneal Endothelial Cells.

Authors:  Kim Santerre; Sergio Cortez Ghio; Stéphanie Proulx
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-10-03       Impact factor: 4.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.